Eli Lilly Weight Loss Pill Foundayo Secures First European Approval in UK
Britain’s medicines regulator authorised Eli Lilly (NYSE: LLY) oral weight-loss and type 2 diabetes pill, Foundayo, on August 10, 2026. This decision makes the United Kingdom the first country in … Read More